Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 AUD | +0.87% | +0.87% | -20.07% |
May. 28 | Ord Minnett Starts Australian Clinical Labs at Buy, Price Target is AU$3.50 | MT |
May. 21 | Australian Clinical Expects Fiscal 2024 Earnings to Fall at Lower End of Forecast | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.07% | 305M | |
+26.08% | 88.38B | |
-23.66% | 77.56B | |
+8.73% | 28.74B | |
+7.45% | 18.45B | |
-13.80% | 16.57B | |
+2.60% | 15.81B | |
+78.26% | 13.65B | |
+82.29% | 13.06B | |
+3.66% | 12.61B |
- Stock Market
- Equities
- ACL Stock
- News Australian Clinical Labs Limited
- Australian Clinical Labs Lowers Final Dividend as Fiscal 2023 Profit Falls; Shares Plunge 14%